Acute tubular necrosis (ATN) is a type of renal azotemia caused by damage to the kidney tubules, leading to cell death. Ischemia, sepsis, heavy metals, and medications can…
Dana V. Rizk, MD, professor of medicine, University of Alabama at Birmingham; and Gerald Appel, MD, professor of medicine and co-director of the Center for Glomerular Disease, Columbia…
NEW YORK (Reuters Health) – US researchers have developed a clinical equation that may enhance the estimation of glomerular filtration rate (GFR) in children with chronic kidney disease,…
NEW YORK (Reuters Health) – Long-term treatment of systemic lupus erythematosus (SLE) with hydroxychloroquine, initiated soon after disease onset, is protective against renal damage, according to study findings…
NEW YORK (Reuters Health) – Passive cycling movements and transcutaneous electrical muscle stimulation during hemodialysis can improve blood pressure and enhance removal of urea and phosphate, according to…
NEW YORK (Reuters Health) – Nephropathy associated with iodinated contrast medium exposure can be fatal, physicians report in the October issue of Mayo Clinic Proceedings. However, the mortality…
NEW YORK (Reuters Health) – Surgery appears to be safe option in treatment of certain elderly patients with renal tumors, German researchers report in the September issue of…
NEW YORK (Reuters Health) – New research suggests that older patients with advanced renal cell carcinoma glean as much benefit from sorafenib as do their younger counterparts. Moreover,…
Rasheed A. Balogun, MD, Associate Professor of Medicine in the Division of Nephrology at the University of Virginia Health System, discusses the risk factors and rising worldwide incidence…
NEW YORK (Reuters Health) – Kidneys transplanted from living donors over the age of 55 are associated with “excellent outcomes” in older transplant recipients, according to data from…
NEW YORK (Reuters Health) – Treatment with the phosphodiesterase inhibitor pentoxifylline can significantly reduce proteinuria in patients with diabetic and other forms of chronic kidney disease, according to…
NEW YORK (Reuters Health) – Vascular-targeted photodynamic therapy (VTP) using the light-activated drug Tookad offers promise as an effective, minimally invasive salvage therapy for men with recurrent prostate…
